Deccan Health Care (BOM:542248) Cyclically Adjusted Revenue per Share: ₹34.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542248 Deccan Health Care Ltd BOM:542248
75 GF Score
Price ₹12.92
GF Value ₹24.93
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Deccan Health Care Cyclically Adjusted Revenue per Share?

Deccan Health Care BOM:542248 -2.05% 75 Cyclically Adjusted Revenue per Share is ₹34.11 as of Jun. 2026. GuruFocus rates BOM:542248 with a GF Score™ of 75/100 and a GF Value™ of ₹24.93 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Deccan Health Care's adjusted revenue per share data for the fiscal year that ended in Mar. 2026 was ₹33.254. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹34.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Deccan Health Care's average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-01), Deccan Health Care's current stock price is ₹ 12.92. Deccan Health Care's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar. 2026 was ₹34.11. Deccan Health Care's Cyclically Adjusted PS Ratio of today is 0.38.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Deccan Health Care was 0.74. The lowest was 0.24. And the median was 0.49.


Deccan Health Care  (BOM:542248) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Deccan Health Care's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.92/34.11
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Deccan Health Care was 0.74. The lowest was 0.24. And the median was 0.49.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Deccan Health Care Cyclically Adjusted Revenue per Share Related Terms


Deccan Health Care Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Deccan Health Care's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deccan Health Care Cyclically Adjusted Revenue per Share Chart

Deccan Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 31.11 34.11

Deccan Health Care Quarterly Data
Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 34.11 0.00

BOM:542248 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deccan Health Care Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Deccan Health Care's Cyclically Adjusted PS Ratio falls into.


BOM:542248
75GF Score
Deccan Health Care Ltd BOM:542248
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Deccan Health Care Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Deccan Health Care's adjusted Revenue per Share data for the fiscal year that ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=33.254/164.2724*164.2724
=33.254

Current CPI (Mar. 2026) = 164.2724.

Deccan Health Care Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201703 18.673 105.196 29.159
201803 29.058 109.786 43.479
201903 31.433 118.202 43.684
202003 26.885 124.705 35.415
202103 21.495 131.771 26.797
202203 21.111 138.822 24.981
202303 35.300 146.865 39.484
202403 32.095 153.035 34.452
202503 29.150 157.552 30.393
202603 33.254 164.272 33.254

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹34.11 mean?
Deccan Health Care (BOM:542248) has a Cyclically Adjusted Revenue per Share of ₹34.11 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Deccan Health Care and its competitors.
Is Deccan Health Care's Cyclically Adjusted Revenue per Share too high?
Deccan Health Care's current Cyclically Adjusted Revenue per Share is ₹34.11. Overall, Deccan Health Care has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's Cyclically Adjusted Revenue per Share compare to ZTS?
Deccan Health Care's Cyclically Adjusted Revenue per Share of ₹34.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Deccan Health Care and its competitors. Deccan Health Care's current Cyclically Adjusted Revenue per Share is ₹34.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹24.93, compared to a current price of ₹12.92 — trading 48.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹34.11. Deccan Health Care's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current Cyclically Adjusted Revenue per Share is ₹34.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Deccan Health Care (BOM:542248) Overvalued in 2026?

Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued. The current stock price of ₹12.92 is trading 48.2% below its estimated GF Value™ of ₹24.93. GuruFocus considers Deccan Health Care to be Significantly Undervalued.

Key valuation signals for BOM:542248:

  • Cyclically Adjusted Revenue per Share: ₹34.11
  • GF Value™: ₹24.93 vs. price of ₹12.92 (48.2% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Deccan Health Care Business Description

Address 6-3-347/17/5/A/Back Position, Dwarakapuri Colony, Punjagutta, Hyderabad, TG, IND, 500082
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
75GF Score

Get the complete analysis for BOM:542248

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹12.92
Price
₹24.93
GF Value